Abstract
This article examines the emerging discipline of food genomics to probe the nature and transmission mechanism of epigenetic changes to the genome related to nutrition, and its impact on policy specifically, and the ethics in 21st century human societies more broadly. The overarching aim is to make recommendations for global health policy that will benefit from advances in personalized genomics knowledge in the context of food. The discussion explores the challenging possibility of intergenerational transfer and retention of environmental signals and imprints on the genome. In addition, the article draws on the socio-ethical aspects of making decisions about how to use that information in order to benefit present and future generations equitably. Personalized nutrition genomics could benefit from unique epigenetic signatures of individuals for the purposes of personalized dietary interventions. An epigenetic information society will face obvious social choices between a policy of laissez-faire versus a policy of intervention and rehabilitation in global health. Some will also undoubtedly argue that the inevitability of natural selection invariably points to not intervening (too much, if at all) in such a transgenerational way (if we can help it) as the genome will adapt to any viable environmental stress through its inherent plasticity, regardless of the resulting social conditions through which it materializes. The article concludes that ultimately, global health will benefit from promoting appropriate governance of the biological informational value of foods together with strong educational programs for the public.
Keywords: Food genomics, global health, information food, information society, intergenerational equity, nutritional epigenetics, personalized nutrition.
Current Pharmacogenomics and Personalized Medicine
Title:Food Genomics and the Information Society: Synergies for Global Health
Volume: 11
Author(s): Djims Milius
Affiliation:
Keywords: Food genomics, global health, information food, information society, intergenerational equity, nutritional epigenetics, personalized nutrition.
Abstract: This article examines the emerging discipline of food genomics to probe the nature and transmission mechanism of epigenetic changes to the genome related to nutrition, and its impact on policy specifically, and the ethics in 21st century human societies more broadly. The overarching aim is to make recommendations for global health policy that will benefit from advances in personalized genomics knowledge in the context of food. The discussion explores the challenging possibility of intergenerational transfer and retention of environmental signals and imprints on the genome. In addition, the article draws on the socio-ethical aspects of making decisions about how to use that information in order to benefit present and future generations equitably. Personalized nutrition genomics could benefit from unique epigenetic signatures of individuals for the purposes of personalized dietary interventions. An epigenetic information society will face obvious social choices between a policy of laissez-faire versus a policy of intervention and rehabilitation in global health. Some will also undoubtedly argue that the inevitability of natural selection invariably points to not intervening (too much, if at all) in such a transgenerational way (if we can help it) as the genome will adapt to any viable environmental stress through its inherent plasticity, regardless of the resulting social conditions through which it materializes. The article concludes that ultimately, global health will benefit from promoting appropriate governance of the biological informational value of foods together with strong educational programs for the public.
Export Options
About this article
Cite this article as:
Milius Djims, Food Genomics and the Information Society: Synergies for Global Health, Current Pharmacogenomics and Personalized Medicine 2013; 11 (4) . https://dx.doi.org/10.2174/18756921113119990009
DOI https://dx.doi.org/10.2174/18756921113119990009 |
Print ISSN 1875-6921 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6913 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Indole Curcumin Reverses Multidrug Resistance by Reducing the Expression of ABCB1 and COX2 in Induced Multidrug Resistant Human Lung Cancer Cells
Letters in Drug Design & Discovery Nitric Oxide and Disorders of the Erythrocyte: Emerging Roles and Therapeutic Targets
Cardiovascular & Hematological Disorders-Drug Targets The Multifunctional Protein p62 and Its Mechanistic Roles in Cancers
Current Cancer Drug Targets Activation of PI3K/Akt/NF-kB Signaling Mediates Swedish Snus Induced Proliferation and Apoptosis Evasion in the Rat Forestomach: Modulation by Blueberry
Anti-Cancer Agents in Medicinal Chemistry Cdc20: A Potential Novel Therapeutic Target for Cancer Treatment
Current Pharmaceutical Design Polymorphisms in Methotrexate Pathways: What Is Clinically Relevant, What Is Not, and What Is Promising
Current Drug Metabolism Biomarkers in Amyotrophic Lateral Sclerosis: Is There A Neurovascular Pathway?
Current Neurovascular Research On Molecular Graph Comparison
Current Computer-Aided Drug Design Human T-Cell Leukemia Virus Type 1: Transition from Latent Infection to Pathogenic Progression and Implications for Molecular Therapy
Current Cancer Therapy Reviews Dimethyl-Carbamic Acid 2,3-Bis-Dimethylcarbamoyloxy-6-(4-Ethyl-Piperazine- 1-Carbonyl)-Phenyl Ester: A Novel Multi-Target Therapeutic Approach to Neuroprotection
Medicinal Chemistry A Facile and Microwave-assisted Rapid Synthesis of 2-Arylamino-4-(3′-indolyl)- thiazoles as Apoptosis Inducing Cytotoxic Agents
Anti-Cancer Agents in Medicinal Chemistry Microenvironment and Brain Tumor Stem Cell Maintenance: Impact of the Niche
Anti-Cancer Agents in Medicinal Chemistry Sulforaphane Treatment of Young Men with Autism Spectrum Disorder
CNS & Neurological Disorders - Drug Targets Prospects for Anti-Neoplastic Therapies Based on Telomere Biology
Current Cancer Drug Targets Exploiting Novel Cell Cycle Targets in the Development of Anticancer Agents
Current Cancer Drug Targets Clustering and Sampling of the c-Met Conformational Space: A Computational Drug Discovery Study
Combinatorial Chemistry & High Throughput Screening The Possible Use of Terpene Compounds in DC Immunotherapy against Cancer
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Nuclear Architecture and Gene Expression in the Quest for Novel Therapeutics
Current Pharmaceutical Design Subject Index to Volume 4
Current Medicinal Chemistry - Anti-Cancer Agents Novel Curcumin Inspired Antineoplastic 1-Sulfonyl-4-Piperidones: Design, Synthesis and Molecular Modeling Studies
Anti-Cancer Agents in Medicinal Chemistry